The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery and Optimization of Glucose Uptake Inhibitors.EBI
Kadmon
Compounds and therapeutic uses thereofBDB
Viogen Biosciences
1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitorsBDB
Angelini Acraf
Benzenesulfonamide compounds and their use as therapeutic agentsBDB
Xenon Pharmaceuticals
3′ end caps, 5′ end caps and combinations thereof for therapeutic RNABDB
Novartis
Triazole pyridyl compounds as agonists of the APJ receptorBDB
Amgen
 
Synthesis, crystal structure determination, biological screening and docking studies of N1-substituted derivatives of 2,3-dihydroquinazolin-4(1H)-one as inhibitors of cholinesterases.BDB
University of Sargodha
Beta-amyloid-directed multitarget compounds for the treatment of alzheimer's diseaseBDB
Universitat De Barcelona
Selective PI3K delta inhibitorsBDB
Rhizen Pharmaceuticals